Literature DB >> 25187632

Molecular and phenotypic characterization of Vibrio navarrensis isolates associated with human illness.

Lori M Gladney1, Cheryl L Tarr2.   

Abstract

We characterized 18 Vibrio isolates, including 15 recovered from human clinical specimens, and found that they clustered with two previously characterized Vibrio navarrensis isolates in a phylogenetic analysis. Four of the 18 strains may represent a new Vibrio species, distinct from V. navarrensis. The potential role of V. navarrensis in human disease needs further investigation.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25187632      PMCID： PMC4313256          DOI： 10.1128/JCM.01544-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Polymorphism in repeated 16S rRNA genes is a common property of type strains and environmental isolates of the genus Vibrio.

Authors:  Claudia Moreno; Jaime Romero; Romilio T Espejo
Journal:  Microbiology (Reading)       Date:  2002-04       Impact factor: 2.777

2.  Divergence and redundancy of 16S rRNA sequences in genomes with multiple rrn operons.

Authors:  Silvia G Acinas; Luisa A Marcelino; Vanja Klepac-Ceraj; Martin F Polz
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

3.  Phylogeny and molecular identification of vibrios on the basis of multilocus sequence analysis.

Authors:  F L Thompson; D Gevers; C C Thompson; P Dawyndt; S Naser; B Hoste; C B Munn; J Swings
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

Review 4.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

5.  Vibrio navarrensis sp. nov., a species from sewage.

Authors:  M C Urdaci; M Marchand; E Ageron; J M Arcos; B Sesma; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1991-04

6.  Vibrio navarrensis biotype pommerensis: a new biotype of V. navarrensis isolated in the German Baltic Sea.

Authors:  Joerg Jores; Bernd Appel; Astrid Lewin
Journal:  Syst Appl Microbiol       Date:  2006-03-24       Impact factor: 4.022

7.  Interior-branch and bootstrap tests of phylogenetic trees.

Authors:  T Sitnikova; A Rzhetsky; M Nei
Journal:  Mol Biol Evol       Date:  1995-03       Impact factor: 16.240

8.  A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences.

Authors:  M Kimura
Journal:  J Mol Evol       Date:  1980-12       Impact factor: 2.395

9.  Identification of Vibrio isolates by a multiplex PCR assay and rpoB sequence determination.

Authors:  Cheryl L Tarr; Jayna S Patel; Nancy D Puhr; Evangeline G Sowers; Cheryl A Bopp; Nancy A Strockbine
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

Review 10.  Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae.

Authors:  S M Faruque; M J Albert; J J Mekalanos
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056
View more
  3 in total

1.  Genome Sequences of Vibrio navarrensis, a Potential Human Pathogen.

Authors:  Lori M Gladney; Lee S Katz; Kristen M Knipe; Lori A Rowe; Andrew B Conley; Lavanya Rishishwar; Leonardo Mariño-Ramírez; I King Jordan; Cheryl L Tarr
Journal:  Genome Announc       Date:  2014-11-20

2.  Diversity of Vibrio navarrensis Revealed by Genomic Comparison: Veterinary Isolates Are Related to Strains Associated with Human Illness and Sewage Isolates While Seawater Strains Are More Distant.

Authors:  Keike Schwartz; Cindy Kukuc; Nadja Bier; Karin Taureck; Jens A Hammerl; Eckhard Strauch
Journal:  Front Microbiol       Date:  2017-09-06       Impact factor: 5.640

3.  CRISPR-Cas systems are present predominantly on mobile genetic elements in Vibrio species.

Authors:  Nathan D McDonald; Abish Regmi; Daniel P Morreale; Joseph D Borowski; E Fidelma Boyd
Journal:  BMC Genomics       Date:  2019-02-04       Impact factor: 3.969
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.